| Study period | ||||||
---|---|---|---|---|---|---|---|
Enrollment | Allocation | Post-allocation | |||||
Time point |  − T1 | 0 | T1 | T2 | T3 | T4 | T5 |
Enrollment | |||||||
 Eligibility screen | X |  |  |  |  |  |  |
 Informed consent | X |  |  |  |  |  |  |
 Allocation |  | X |  |  |  |  |  |
Interventions | |||||||
 CACP care |  |  | X |  |  |  |  |
Assessmentsa | |||||||
 Age, sex, race, ethnicity, comorbidities, medications (EHR) | X |  |  |  |  |  |  |
 Social support information (survey) |  | X |  |  |  |  |  |
 HRQoL—EQ-5D (survey) |  | X |  |  | X |  |  |
 Treatment burden—PETS (survey) |  | X |  |  | X |  |  |
 ED visits, unplanned hospitalizations, death (EHR) |  |  |  |  | X | X | X |
 Falls with injury, medication errors with harm |  |  |  |  | X |  |  |
 Program experience (survey and interviewb) |  |  |  | X |  |  |  |